S. Pryor-Tillotson

Statistics

Publications

Citations

311

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

S. Pryor-Tillotson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, calcium homeostasis, and bone metabolism.

Publications per year

1992–1997

Publications

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

John L. Stock, Norman H. Bell, Charles H. Chesnut et al. · The American Journal of Medicine · 1997 · 144 citations

Medicine, Endocrinology, Bone Metabolism +16

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

S. Adámi, M Passeri, S. Ortolani et al. · Bone · 1995 · 142 citations

Medicine, Endocrinology, Bone Metabolism +16

Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy

E. Zysset, Patrick Ammann, A. Jenzer et al. · Bone and Mineral · 1992 · 25 citations

Medicine, Pharmacokinetics, Pharmacology +6

1–3 of 3